Listed

Phathom Pharmaceuticals, Inc.

PHATNasdaqCIK 1783183HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$84.7m, Q3 FY2026
Operating income−$85.0k, Q3 FY2026
Net income−$13.9m, Q3 FY2026
Phathom Pharmaceuticals, Inc., income statement, quarterly
Line itemUnitQ4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Revenue$m0.7Revenue, Q4 FY2023, three months to 2023-12-31$682.0k. XBRL concept us-gaap:Revenues. 10-K filed 2025-03-06, accession 0000950170-25-034183. Derived: 12-month figure less the 9-month figure.Report this figure1.9Revenue, Q1 FY2024, three months to 2024-03-31$1.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-01, accession 0000950170-25-061440.Report this figure7.3Revenue, Q2 FY2024, three months to 2024-06-30$7.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-08-07, accession 0000950170-25-104548.Report this figure16.4Revenue, Q3 FY2024, three months to 2024-09-30$16.4m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-10-30, accession 0001193125-25-257390.Report this figure29.7Revenue, Q4 FY2024, three months to 2024-12-31$29.7m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-26, accession 0001193125-26-073379. Derived: 12-month figure less the 9-month figure.Report this figure28.5Revenue, Q1 FY2025, three months to 2025-03-31$28.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-30, accession 0001193125-26-193946.Report this figure39.5Revenue, Q2 FY2025, three months to 2025-06-30$39.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-30, accession 0001193125-26-324867.Report this figure49.5Revenue, Q3 FY2025, three months to 2025-09-30$49.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure57.6Revenue, Q4 FY2025, three months to 2025-12-31$57.6m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-26, accession 0001193125-26-073379. Derived: 12-month figure less the 9-month figure.Report this figure58.3Revenue, Q1 FY2026, three months to 2026-03-31$58.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-30, accession 0001193125-26-193946.Report this figure74.3Revenue, Q2 FY2026, three months to 2026-06-30$74.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-30, accession 0001193125-26-324867.Report this figure84.7Revenue, Q3 FY2026, three months to 2026-09-30$84.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure
Cost of revenue$m0.2Cost of revenue, Q4 FY2023, three months to 2023-12-31$167.0k. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2025-03-06, accession 0000950170-25-034183. Derived: 12-month figure less the 9-month figure.Report this figure0.4Cost of revenue, Q1 FY2024, three months to 2024-03-31$426.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-05-01, accession 0000950170-25-061440.Report this figure1.4Cost of revenue, Q2 FY2024, three months to 2024-06-30$1.4m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-08-07, accession 0000950170-25-104548.Report this figure2.4Cost of revenue, Q3 FY2024, three months to 2024-09-30$2.4m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-10-30, accession 0001193125-25-257390.Report this figure3.8Cost of revenue, Q4 FY2024, three months to 2024-12-31$3.8m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-02-26, accession 0001193125-26-073379. Derived: 12-month figure less the 9-month figure.Report this figure3.7Cost of revenue, Q1 FY2025, three months to 2025-03-31$3.7m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-04-30, accession 0001193125-26-193946.Report this figure5.0Cost of revenue, Q2 FY2025, three months to 2025-06-30$5.0m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-07-30, accession 0001193125-26-324867.Report this figure6.2Cost of revenue, Q3 FY2025, three months to 2025-09-30$6.2m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure7.6Cost of revenue, Q4 FY2025, three months to 2025-12-31$7.6m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-02-26, accession 0001193125-26-073379. Derived: 12-month figure less the 9-month figure.Report this figure12.0Cost of revenue, Q1 FY2026, three months to 2026-03-31$12.0m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-04-30, accession 0001193125-26-193946.Report this figure15.1Cost of revenue, Q2 FY2026, three months to 2026-06-30$15.1m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-07-30, accession 0001193125-26-324867.Report this figure18.4Cost of revenue, Q3 FY2026, three months to 2026-09-30$18.4m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure
Gross profit$m0.5Gross profit, Q4 FY2023, three months to 2023-12-31$515.0k. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-03-06, accession 0000950170-25-034183. Derived: 12-month figure less the 9-month figure.Report this figure1.5Gross profit, Q1 FY2024, three months to 2024-03-31$1.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-01, accession 0000950170-25-061440.Report this figure5.9Gross profit, Q2 FY2024, three months to 2024-06-30$5.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-07, accession 0000950170-25-104548.Report this figure14.0Gross profit, Q3 FY2024, three months to 2024-09-30$14.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-10-30, accession 0001193125-25-257390.Report this figure25.8Gross profit, Q4 FY2024, three months to 2024-12-31$25.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-26, accession 0001193125-26-073379. Derived: 12-month figure less the 9-month figure.Report this figure24.8Gross profit, Q1 FY2025, three months to 2025-03-31$24.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-04-30, accession 0001193125-26-193946.Report this figure34.5Gross profit, Q2 FY2025, three months to 2025-06-30$34.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-07-30, accession 0001193125-26-324867.Report this figure43.3Gross profit, Q3 FY2025, three months to 2025-09-30$43.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure49.9Gross profit, Q4 FY2025, three months to 2025-12-31$49.9m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-26, accession 0001193125-26-073379. Derived: 12-month figure less the 9-month figure.Report this figure46.3Gross profit, Q1 FY2026, three months to 2026-03-31$46.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-04-30, accession 0001193125-26-193946.Report this figure59.2Gross profit, Q2 FY2026, three months to 2026-06-30$59.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-07-30, accession 0001193125-26-324867.Report this figure66.4Gross profit, Q3 FY2026, three months to 2026-09-30$66.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure
Research and development$m13.4Research and development, Q4 FY2023, three months to 2023-12-31$13.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-06, accession 0000950170-25-034183. Derived: 12-month figure less the 9-month figure.Report this figure9.4Research and development, Q1 FY2024, three months to 2024-03-31$9.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-01, accession 0000950170-25-061440.Report this figure7.4Research and development, Q2 FY2024, three months to 2024-06-30$7.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0000950170-25-104548.Report this figure8.7Research and development, Q3 FY2024, three months to 2024-09-30$8.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-10-30, accession 0001193125-25-257390.Report this figure8.6Research and development, Q4 FY2024, three months to 2024-12-31$8.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001193125-26-073379. Derived: 12-month figure less the 9-month figure.Report this figure9.2Research and development, Q1 FY2025, three months to 2025-03-31$9.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-04-30, accession 0001193125-26-193946.Report this figure9.1Research and development, Q2 FY2025, three months to 2025-06-30$9.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-07-30, accession 0001193125-26-324867.Report this figure7.0Research and development, Q3 FY2025, three months to 2025-09-30$7.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure7.5Research and development, Q4 FY2025, three months to 2025-12-31$7.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001193125-26-073379. Derived: 12-month figure less the 9-month figure.Report this figure7.8Research and development, Q1 FY2026, three months to 2026-03-31$7.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-04-30, accession 0001193125-26-193946.Report this figure7.8Research and development, Q2 FY2026, three months to 2026-06-30$7.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-07-30, accession 0001193125-26-324867.Report this figure8.7Research and development, Q3 FY2026, three months to 2026-09-30$8.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure
Selling, general and administrative$m57.0Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$57.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2025-03-06, accession 0000950170-25-034183. Derived: 12-month figure less the 9-month figure.Report this figure62.0Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$62.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-01, accession 0000950170-25-061440.Report this figure75.9Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$75.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-07, accession 0000950170-25-104548.Report this figure76.1Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$76.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-10-30, accession 0001193125-25-257390.Report this figure76.7Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$76.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-26, accession 0001193125-26-073379. Derived: 12-month figure less the 9-month figure.Report this figure94.5Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$94.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-04-30, accession 0001193125-26-193946.Report this figure85.3Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$85.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-07-30, accession 0001193125-26-324867.Report this figure51.6Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$51.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure48.4Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$48.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-26, accession 0001193125-26-073379. Derived: 12-month figure less the 9-month figure.Report this figure54.0Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$54.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-04-30, accession 0001193125-26-193946.Report this figure55.3Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$55.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-07-30, accession 0001193125-26-324867.Report this figure57.7Selling, general and administrative, Q3 FY2026, three months to 2026-09-30$57.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure
Operating income$m(69.9)Operating income, Q4 FY2023, three months to 2023-12-31−$69.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-06, accession 0000950170-25-034183. Derived: 12-month figure less the 9-month figure.Report this figure(70.0)Operating income, Q1 FY2024, three months to 2024-03-31−$70.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-01, accession 0000950170-25-061440.Report this figure(77.3)Operating income, Q2 FY2024, three months to 2024-06-30−$77.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0000950170-25-104548.Report this figure(70.8)Operating income, Q3 FY2024, three months to 2024-09-30−$70.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-30, accession 0001193125-25-257390.Report this figure(59.4)Operating income, Q4 FY2024, three months to 2024-12-31−$59.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-073379. Derived: 12-month figure less the 9-month figure.Report this figure(78.9)Operating income, Q1 FY2025, three months to 2025-03-31−$78.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-30, accession 0001193125-26-193946.Report this figure(59.9)Operating income, Q2 FY2025, three months to 2025-06-30−$59.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-30, accession 0001193125-26-324867.Report this figure(15.3)Operating income, Q3 FY2025, three months to 2025-09-30−$15.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure(5.9)Operating income, Q4 FY2025, three months to 2025-12-31−$5.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-073379. Derived: 12-month figure less the 9-month figure.Report this figure(15.5)Operating income, Q1 FY2026, three months to 2026-03-31−$15.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-30, accession 0001193125-26-193946.Report this figure(4.0)Operating income, Q2 FY2026, three months to 2026-06-30−$4.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-30, accession 0001193125-26-324867.Report this figure(0.1)Operating income, Q3 FY2026, three months to 2026-09-30−$85.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure
Interest expense$m13.0Interest expense, Q4 FY2023, three months to 2023-12-31$13.0m. XBRL concept us-gaap:InterestExpense. 10-K/A filed 2024-06-14, accession 0000950170-24-073629. Derived: 12-month figure less the 9-month figure.Report this figure17.2Interest expense, Q1 FY2024, three months to 2024-03-31$17.2m. XBRL concept us-gaap:InterestExpense. 10-Q/A filed 2024-06-14, accession 0000950170-24-073628.Report this figure17.8Interest expense, Q2 FY2024, three months to 2024-06-30$17.8m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-08-08, accession 0000950170-24-093885.Report this figure18.5Interest expense, Q3 FY2024, three months to 2024-09-30$18.5m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-10-30, accession 0001193125-25-257390.Report this figure18.6Interest expense, Q4 FY2024, three months to 2024-12-31$18.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-26, accession 0001193125-26-073379. Derived: 12-month figure less the 9-month figure.Report this figure18.1Interest expense, Q1 FY2025, three months to 2025-03-31$18.1m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-04-30, accession 0001193125-26-193946.Report this figure17.5Interest expense, Q2 FY2025, three months to 2025-06-30$17.5m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-07-30, accession 0001193125-26-324867.Report this figure16.1Interest expense, Q3 FY2025, three months to 2025-09-30$16.1m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure16.4Interest expense, Q4 FY2025, three months to 2025-12-31$16.4m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-26, accession 0001193125-26-073379. Derived: 12-month figure less the 9-month figure.Report this figure15.8Interest expense, Q1 FY2026, three months to 2026-03-31$15.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-04-30, accession 0001193125-26-193946.Report this figure15.1Interest expense, Q2 FY2026, three months to 2026-06-30$15.1m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-07-30, accession 0001193125-26-324867.Report this figure15.4Interest expense, Q3 FY2026, three months to 2026-09-30$15.4m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure
Net income$m(79.6)Net income, Q4 FY2023, three months to 2023-12-31−$79.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-06, accession 0000950170-25-034183. Derived: 12-month figure less the 9-month figure.Report this figure(82.9)Net income, Q1 FY2024, three months to 2024-03-31−$82.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-30, accession 0001193125-25-257390.Report this figure(91.4)Net income, Q2 FY2024, three months to 2024-06-30−$91.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-30, accession 0001193125-25-257390.Report this figure(85.6)Net income, Q3 FY2024, three months to 2024-09-30−$85.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-30, accession 0001193125-25-257390.Report this figure(74.5)Net income, Q4 FY2024, three months to 2024-12-31−$74.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-073379. Derived: 12-month figure less the 9-month figure.Report this figure(94.3)Net income, Q1 FY2025, three months to 2025-03-31−$94.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure(75.8)Net income, Q2 FY2025, three months to 2025-06-30−$75.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure(30.0)Net income, Q3 FY2025, three months to 2025-09-30−$30.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure(21.1)Net income, Q4 FY2025, three months to 2025-12-31−$21.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-073379. Derived: 12-month figure less the 9-month figure.Report this figure(30.4)Net income, Q1 FY2026, three months to 2026-03-31−$30.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure(17.6)Net income, Q2 FY2026, three months to 2026-06-30−$17.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure(13.9)Net income, Q3 FY2026, three months to 2026-09-30−$13.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure
Diluted EPS$ per sharenot reported(1.42)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$1.42 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-01, accession 0000950170-25-061440.Report this figure(1.56)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$1.56 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0000950170-25-104548.Report this figure(1.32)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$1.32 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-30, accession 0001193125-25-257390.Report this figurenot reported(1.31)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$1.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-30, accession 0001193125-26-193946.Report this figure(1.05)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$1.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-30, accession 0001193125-26-324867.Report this figure(0.41)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.41 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figurenot reported(0.37)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.37 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-30, accession 0001193125-26-193946.Report this figure(0.21)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-30, accession 0001193125-26-324867.Report this figure(0.16)Diluted EPS, Q3 FY2026, three months to 2026-09-30−$0.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure
Basic EPS$ per sharenot reported(1.42)Basic EPS, Q1 FY2024, three months to 2024-03-31−$1.42 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-01, accession 0000950170-25-061440.Report this figure(1.56)Basic EPS, Q2 FY2024, three months to 2024-06-30−$1.56 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0000950170-25-104548.Report this figure(1.32)Basic EPS, Q3 FY2024, three months to 2024-09-30−$1.32 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-30, accession 0001193125-25-257390.Report this figurenot reported(1.31)Basic EPS, Q1 FY2025, three months to 2025-03-31−$1.31 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-30, accession 0001193125-26-193946.Report this figure(1.05)Basic EPS, Q2 FY2025, three months to 2025-06-30−$1.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-30, accession 0001193125-26-324867.Report this figure(0.41)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.41 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figurenot reported(0.37)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.37 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-30, accession 0001193125-26-193946.Report this figure(0.21)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.21 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-30, accession 0001193125-26-324867.Report this figure(0.16)Basic EPS, Q3 FY2026, three months to 2026-09-30−$0.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure

Balance sheet

Cash and equivalents$184.6m, Q3 FY2026
Long-term debt$165.5m, Q3 FY2026
Shareholders' equity−$347.6m, Q3 FY2026
Phathom Pharmaceuticals, Inc., balance sheet, quarterly
Line itemUnitFY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Cash and equivalents$m381Cash and equivalents, FY2023, at 2023-12-31$381.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-06, accession 0000950170-25-034183.Report this figure322Cash and equivalents, Q1 FY2024, at 2024-03-31$322.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q/A filed 2024-06-14, accession 0000950170-24-073628.Report this figure276Cash and equivalents, Q2 FY2024, at 2024-06-30$276.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-08, accession 0000950170-24-093885.Report this figure335Cash and equivalents, Q3 FY2024, at 2024-09-30$334.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0000950170-24-123264.Report this figure297Cash and equivalents, FY2024, at 2024-12-31$297.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-26, accession 0001193125-26-073379.Report this figure212Cash and equivalents, Q1 FY2025, at 2025-03-31$212.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-01, accession 0000950170-25-061440.Report this figure150Cash and equivalents, Q2 FY2025, at 2025-06-30$149.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0000950170-25-104548.Report this figure135Cash and equivalents, Q3 FY2025, at 2025-09-30$135.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-10-30, accession 0001193125-25-257390.Report this figure130Cash and equivalents, FY2025, at 2025-12-31$130.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure181Cash and equivalents, Q1 FY2026, at 2026-03-31$180.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-04-30, accession 0001193125-26-193946.Report this figure182Cash and equivalents, Q2 FY2026, at 2026-06-30$182.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-30, accession 0001193125-26-324867.Report this figure185Cash and equivalents, Q3 FY2026, at 2026-09-30$184.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure
Current assets$m397Current assets, FY2023, at 2023-12-31$397.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-06, accession 0000950170-25-034183.Report this figure340Current assets, Q1 FY2024, at 2024-03-31$340.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q/A filed 2024-06-14, accession 0000950170-24-073628.Report this figure305Current assets, Q2 FY2024, at 2024-06-30$304.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-093885.Report this figure374Current assets, Q3 FY2024, at 2024-09-30$373.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123264.Report this figure360Current assets, FY2024, at 2024-12-31$360.1m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-26, accession 0001193125-26-073379.Report this figure265Current assets, Q1 FY2025, at 2025-03-31$264.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-01, accession 0000950170-25-061440.Report this figure219Current assets, Q2 FY2025, at 2025-06-30$218.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-104548.Report this figure208Current assets, Q3 FY2025, at 2025-09-30$207.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-10-30, accession 0001193125-25-257390.Report this figure229Current assets, FY2025, at 2025-12-31$229.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure277Current assets, Q1 FY2026, at 2026-03-31$276.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-04-30, accession 0001193125-26-193946.Report this figure296Current assets, Q2 FY2026, at 2026-06-30$295.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-07-30, accession 0001193125-26-324867.Report this figure308Current assets, Q3 FY2026, at 2026-09-30$308.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure
Total assets$m414Total assets, FY2023, at 2023-12-31$413.8m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-06, accession 0000950170-25-034183.Report this figure356Total assets, Q1 FY2024, at 2024-03-31$356.5m. XBRL concept us-gaap:Assets. 10-Q/A filed 2024-06-14, accession 0000950170-24-073628.Report this figure319Total assets, Q2 FY2024, at 2024-06-30$319.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0000950170-24-093885.Report this figure387Total assets, Q3 FY2024, at 2024-09-30$387.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0000950170-24-123264.Report this figure378Total assets, FY2024, at 2024-12-31$378.3m. XBRL concept us-gaap:Assets. 10-K filed 2026-02-26, accession 0001193125-26-073379.Report this figure294Total assets, Q1 FY2025, at 2025-03-31$294.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-01, accession 0000950170-25-061440.Report this figure250Total assets, Q2 FY2025, at 2025-06-30$250.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0000950170-25-104548.Report this figure240Total assets, Q3 FY2025, at 2025-09-30$240.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-10-30, accession 0001193125-25-257390.Report this figure259Total assets, FY2025, at 2025-12-31$259.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure305Total assets, Q1 FY2026, at 2026-03-31$305.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-04-30, accession 0001193125-26-193946.Report this figure327Total assets, Q2 FY2026, at 2026-06-30$327.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-30, accession 0001193125-26-324867.Report this figure345Total assets, Q3 FY2026, at 2026-09-30$345.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure
Current liabilities$m38.8Current liabilities, FY2023, at 2023-12-31$38.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-06, accession 0000950170-25-034183.Report this figure43.5Current liabilities, Q1 FY2024, at 2024-03-31$43.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q/A filed 2024-06-14, accession 0000950170-24-073628.Report this figure47.0Current liabilities, Q2 FY2024, at 2024-06-30$47.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-093885.Report this figure65.3Current liabilities, Q3 FY2024, at 2024-09-30$65.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123264.Report this figure85.7Current liabilities, FY2024, at 2024-12-31$85.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-26, accession 0001193125-26-073379.Report this figure74.0Current liabilities, Q1 FY2025, at 2025-03-31$74.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-01, accession 0000950170-25-061440.Report this figure91.8Current liabilities, Q2 FY2025, at 2025-06-30$91.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-104548.Report this figure93.1Current liabilities, Q3 FY2025, at 2025-09-30$93.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-10-30, accession 0001193125-25-257390.Report this figure132Current liabilities, FY2025, at 2025-12-31$132.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure125Current liabilities, Q1 FY2026, at 2026-03-31$125.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-04-30, accession 0001193125-26-193946.Report this figure154Current liabilities, Q2 FY2026, at 2026-06-30$153.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-07-30, accession 0001193125-26-324867.Report this figure175Current liabilities, Q3 FY2026, at 2026-09-30$174.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure
Total liabilities$m487Total liabilities, FY2023, at 2023-12-31$486.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-06, accession 0000950170-25-034183.Report this figure505Total liabilities, Q1 FY2024, at 2024-03-31$505.0m. XBRL concept us-gaap:Liabilities. 10-Q/A filed 2024-06-14, accession 0000950170-24-073628.Report this figure553Total liabilities, Q2 FY2024, at 2024-06-30$553.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0000950170-24-093885.Report this figure574Total liabilities, Q3 FY2024, at 2024-09-30$574.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0000950170-24-123264.Report this figure632Total liabilities, FY2024, at 2024-12-31$631.9m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-26, accession 0001193125-26-073379.Report this figure633Total liabilities, Q1 FY2025, at 2025-03-31$632.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-01, accession 0000950170-25-061440.Report this figure656Total liabilities, Q2 FY2025, at 2025-06-30$656.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0000950170-25-104548.Report this figure663Total liabilities, Q3 FY2025, at 2025-09-30$662.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-10-30, accession 0001193125-25-257390.Report this figure697Total liabilities, FY2025, at 2025-12-31$697.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure642Total liabilities, Q1 FY2026, at 2026-03-31$642.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-04-30, accession 0001193125-26-193946.Report this figure671Total liabilities, Q2 FY2026, at 2026-06-30$671.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-07-30, accession 0001193125-26-324867.Report this figure693Total liabilities, Q3 FY2026, at 2026-09-30$692.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure
Long-term debt$m138Long-term debt, FY2023, at 2023-12-31$137.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-03-06, accession 0000950170-25-034183.Report this figure149Long-term debt, Q1 FY2024, at 2024-03-31$149.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q/A filed 2024-06-14, accession 0000950170-24-073628.Report this figure174Long-term debt, Q2 FY2024, at 2024-06-30$174.4m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-08, accession 0000950170-24-093885.Report this figure176Long-term debt, Q3 FY2024, at 2024-09-30$175.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123264.Report this figure201Long-term debt, FY2024, at 2024-12-31$201.4m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-02-26, accession 0001193125-26-073379.Report this figure203Long-term debt, Q1 FY2025, at 2025-03-31$203.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-01, accession 0000950170-25-061440.Report this figure205Long-term debt, Q2 FY2025, at 2025-06-30$205.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-07, accession 0000950170-25-104548.Report this figure207Long-term debt, Q3 FY2025, at 2025-09-30$207.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-10-30, accession 0001193125-25-257390.Report this figure209Long-term debt, FY2025, at 2025-12-31$209.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure164Long-term debt, Q1 FY2026, at 2026-03-31$163.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-04-30, accession 0001193125-26-193946.Report this figure165Long-term debt, Q2 FY2026, at 2026-06-30$164.6m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-07-30, accession 0001193125-26-324867.Report this figure166Long-term debt, Q3 FY2026, at 2026-09-30$165.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure
Current portion of debt$m0.0Current portion of debt, FY2023, at 2023-12-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2025-03-06, accession 0000950170-25-034183.Report this figure0.0Current portion of debt, Q1 FY2024, at 2024-03-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q/A filed 2024-06-14, accession 0000950170-24-073628.Report this figure0.0Current portion of debt, Q2 FY2024, at 2024-06-30$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-093885.Report this figure0.0Current portion of debt, Q3 FY2024, at 2024-09-30$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123264.Report this figure0.0Current portion of debt, FY2024, at 2024-12-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2026-02-26, accession 0001193125-26-073379.Report this figure0.0Current portion of debt, Q1 FY2025, at 2025-03-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-05-01, accession 0000950170-25-061440.Report this figure0.0Current portion of debt, Q2 FY2025, at 2025-06-30$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-104548.Report this figure0.0Current portion of debt, Q3 FY2025, at 2025-09-30$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-10-30, accession 0001193125-25-257390.Report this figure0.0Current portion of debt, FY2025, at 2025-12-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure0.0Current portion of debt, Q1 FY2026, at 2026-03-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-04-30, accession 0001193125-26-193946.Report this figure0.0Current portion of debt, Q2 FY2026, at 2026-06-30$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-07-30, accession 0001193125-26-324867.Report this figure0.0Current portion of debt, Q3 FY2026, at 2026-09-30$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure
Shareholders' equity$m(72.8)Shareholders' equity, FY2023, at 2023-12-31−$72.8m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-26, accession 0001193125-26-073379.Report this figure(149)Shareholders' equity, Q1 FY2024, at 2024-03-31−$148.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-30, accession 0001193125-25-257390.Report this figure(234)Shareholders' equity, Q2 FY2024, at 2024-06-30−$233.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-30, accession 0001193125-25-257390.Report this figure(187)Shareholders' equity, Q3 FY2024, at 2024-09-30−$187.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-30, accession 0001193125-25-257390.Report this figure(254)Shareholders' equity, FY2024, at 2024-12-31−$253.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure(338)Shareholders' equity, Q1 FY2025, at 2025-03-31−$338.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure(406)Shareholders' equity, Q2 FY2025, at 2025-06-30−$405.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure(423)Shareholders' equity, Q3 FY2025, at 2025-09-30−$422.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure(438)Shareholders' equity, FY2025, at 2025-12-31−$438.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure(337)Shareholders' equity, Q1 FY2026, at 2026-03-31−$337.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure(344)Shareholders' equity, Q2 FY2026, at 2026-06-30−$344.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure(348)Shareholders' equity, Q3 FY2026, at 2026-09-30−$347.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure

Cash flow

Operating cash flow$1.8m, Q3 FY2026
Capital expenditure$110.0k, Q3 FY2026
Phathom Pharmaceuticals, Inc., cash flow, quarterly
Line itemUnitQ4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Operating cash flow$m(43.8)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$43.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-06, accession 0000950170-25-034183. Derived: 12-month figure less the 9-month figure.Report this figure(69.0)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$69.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-01, accession 0000950170-25-061440.Report this figure(70.7)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$70.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0000950170-25-104548. Derived: 6-month figure less the 3-month figure.Report this figure(63.6)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$63.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-30, accession 0001193125-25-257390. Derived: 9-month figure less the 6-month figure.Report this figure(63.5)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$63.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001193125-26-073379. Derived: 12-month figure less the 9-month figure.Report this figure(84.9)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$84.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-30, accession 0001193125-26-193946.Report this figure(62.7)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$62.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-30, accession 0001193125-26-324867. Derived: 6-month figure less the 3-month figure.Report this figure(14.1)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$14.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-29, accession 0001193125-26-436961. Derived: 9-month figure less the 6-month figure.Report this figure(5.0)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$5.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001193125-26-073379. Derived: 12-month figure less the 9-month figure.Report this figure(15.6)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$15.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-30, accession 0001193125-26-193946.Report this figure(1.9)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$1.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-30, accession 0001193125-26-324867. Derived: 6-month figure less the 3-month figure.Report this figure1.8Operating cash flow, Q3 FY2026, three months to 2026-09-30$1.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-29, accession 0001193125-26-436961. Derived: 9-month figure less the 6-month figure.Report this figure
Capital expenditure$m0.5Capital expenditure, Q4 FY2023, three months to 2023-12-31$475.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-06, accession 0000950170-25-034183. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$40.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-01, accession 0000950170-25-061440.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$46.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-07, accession 0000950170-25-104548. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$44.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-30, accession 0001193125-25-257390. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$5.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001193125-26-073379. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$18.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-30, accession 0001193125-26-193946.Report this figure0.1Capital expenditure, Q2 FY2025, three months to 2025-06-30$97.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-30, accession 0001193125-26-324867. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$27.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-29, accession 0001193125-26-436961. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2025, three months to 2025-12-31$87.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001193125-26-073379. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2026, three months to 2026-03-31$61.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-30, accession 0001193125-26-193946.Report this figure0.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$44.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-30, accession 0001193125-26-324867. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2026, three months to 2026-09-30$110.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-29, accession 0001193125-26-436961. Derived: 9-month figure less the 6-month figure.Report this figure

Shares

Diluted shares (weighted)84.89m, Q3 FY2026
Phathom Pharmaceuticals, Inc., shares, quarterly
Line itemUnitQ1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Diluted shares (weighted)m shares42.4Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3142,354,520 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q/A filed 2024-06-14, accession 0000950170-24-073628.Report this figure48.5Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3048,500,516 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0000950170-24-093885.Report this figure56.8Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3056,782,379 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0000950170-24-123264.Report this figure58.4Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3158,371,480 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-01, accession 0000950170-25-061440.Report this figure58.6Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3058,558,145 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0000950170-25-104548.Report this figure64.6Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3064,627,847 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-30, accession 0001193125-25-257390.Report this figure72.0Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3171,969,411 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-30, accession 0001193125-26-193946.Report this figure72.5Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3072,466,203 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-30, accession 0001193125-26-324867.Report this figure73.4Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3073,396,435 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure82.1Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3182,050,618 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-30, accession 0001193125-26-193946.Report this figure83.7Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3083,747,104 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-30, accession 0001193125-26-324867.Report this figure84.9Diluted shares (weighted), Q3 FY2026, three months to 2026-09-3084,892,631 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure

Shares outstanding: 81.29mShares outstanding, period not labelled, at 2026-10-2781,291,520 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-10-29, accession 0001193125-26-436961.Report this figure at Oct 27, 2026, from the cover of the 10-Q filed Oct 29, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 07:19 ET. Listed shows no prices and gives no investment advice.